Skip to main content
. Author manuscript; available in PMC: 2012 Jan 28.
Published in final edited form as: AIDS. 2011 Jan 28;25(3):357–365. doi: 10.1097/QAD.0b013e32834171f8

Table 1.

Antiretroviral Central Nervous System Penetration Scoring System: CNS penetration effectiveness score

Drug Class CPE Score

1 0.5 0

Nucleoside Reverse Transcriptase Inhibitor (NRTI) Abacavir Emtricitabine Adefovir
Zidovudine Lamivudine Zalcitabine
Stavudine Didanosine
Tenofovir

Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Delavirdine Efavirenz
Nevirapine

Protease Inhibitor (PI)* Amprenavir-r Amprenavir Nelfinavir
Darunavir Atazanavir Ritonavir
Fosamprenavir-r Atazanavir-r Saquinavir
Lopinavir-r Fosamprenavir Saquinavir-r
Indinavir-r Indinavir Tipranavir-r

Integrase Inhibitors Elvitegravir
Raltegravir

Entry Inhibitors Vicriviroc Enfuvirtide
Maraviroc T-1249
*

Antiretroviral Central Nervous System (ARV CNS); CNS penetration effectiveness (CPE); Amprenavir-r: Ritonavir boosted Amprenavir; Fosamprenavir-r: Ritonavir boosted Fosamprenavir; Lopinavir-r: Ritonavir boosted Lopinavir; Indinavir-r: Ritonavir boosted Indinavir; Atazanavir-r: Ritonavir boosted Atazanavir; Saquinavir-r: Ritonavir boosted Saquinavir; Tipranavir-r: Ritonavir boosted Tipranavir